“Chimeric Antigen Receptor T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: A Canadian Perspective”. Canadian Hematology Today, vol. 1, no. 2, July 2022, pp. 26–33, https://doi.org/10.58931/cht.2022.1214.